The Annual Male Breast Cancer Global Alliance Conference brings together male survivors, their families, friends and supporters with top medical professionals and leading experts from the breast cancer research and oncology fields. The international conference, which focuses on increasing awareness and education about breast cancer in men, showcases the latest in research developments and clinical trials with an impressive line-up of speakers from leading organizations around the world. Join us for this “virtual” day of sharing, learning and camaraderie!
Oliver Bogler, PhD, Breast Cancer Survivor, Director, NCI Center for Cancer Training in
Dr. Bogler was diagnosed with Stage III cancer in 2012 while working as a cancer biologist at the University of Texas MD Anderson Cancer Center. He completed active treatment in 2013 and has participated in several clinical trials. Dr. Bogler is currently the Director of the Center for Cancer Training at the National Cancer Institute (NCI) in Bethesda, MD.
Fatima Cardoso, MD, Director, Breast Unit, Champalimaud Clinical Center in Lisbon, Portugal
Dr. Cardoso is actively involved in many Stage I-IV breast cancer clinical trials and is deeply involved in the field of cancer policy, accessibility, and inequalities. She is the Founder and President of the Advanced Breast Cancer (ABC) Global Alliance, as well as the Founder and Chair of the ABC International Consensus Guidelines Conference.
Sharon Giordano, MD, MPH, FASCO, Colin Powell Chair for Cancer Research; Chair, Department of Health Services Research; Professor of Medicine, Department of Breast Medical Oncology;
The University of Texas MD Anderson Cancer Center; Houston, TX
Dr. Giordano is a medical oncologist specializing in the care of patients with breast cancer. Her work focuses on quality of health care delivery, disparities, outcomes for breast cancer patients, late effects of treatment, and male breast cancer.
José Pablo Leone, MD, Director, Program for Breast Cancer in Men
Assistant Professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute,
Dr. Leone’s clinical research focuses on brain metastases, male breast cancer and novel therapies in the treatment of breast cancer; he has co-authored 58 peer-reviewed articles and participated in 3 clinical trials in the past 15 years.
Kara N. Maxwell, MD, PhD, Assistant Professor of Medicine & Genetics, Perelman School of Medicine, University of Pennsylvania; Staff Physician, Corporal Michael Crescenz VA Medical Center, Philadelphia, PA
Dr. Maxwell is the Director of the Men and BRCA Program within the Basser Center for BRCA at Penn Medicine and also the Director of the Cancer Genetics program at the Philadelphia VA.
Ingrid A. Mayer, MD, MSCI; Vice President, Global Clinical Strategy Head – Women’s Cancers, AstraZeneca Late Development Oncology, Gaithersburg, Maryland
Dr. Mayer’s role is to pioneer and expand novel translational global research and innovative clinical trial development in breast cancer that accelerates the approval of established and novel drugs in the key areas of excellence at AstraZeneca, tumor resistance/targeted therapies, DNA damage response, antibody-drug conjugates, and immuno-oncology.
Dr. Nick Orr, PhD, School of Medicine, Dentistry and Biomedical Sciences, Patrick G. Johnston Centre for Cancer Research at Queen’s University in Belfast, Ireland
Dr. Orr is the Lead Researcher for a new international consortium working to uncover genes that lead to breast cancer in men.
Ben H. Park, MD, PhD, Director, Vanderbilt-Ingram Cancer Center, Cornelius Abernathy Craig Chair, Professor of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center in Nashville, TN
Dr. Park is an internationally renowned physician, scientist, and breast cancer expert with a specialty in male breast cancer research and clinical care of men with breast cancer.
Carolien Schröder, MD, PhD, Staff Member, Medical Oncology, Department, Antoni Van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands
Dr. Schröder’s research is focused on pre-clinical and clinical intervention strategies directed at the breast cancer microenvironment and metastases, early clinical trials with novel anticancer agents, and large-scale registration and translational trials for rare subgroups including male and inflammatory breast cancer.
Matthew Ellis, MD, BChir, PhD, FRCP, Senior Vice President, Early Oncology, Oncology R&D, AstraZeneca.
Dr. Ellis is a world-renowned clinician and researcher of the molecular profiling of breast cancer who leads a global community of over 1000 scientists working to bring the next wave of oncology medicines from target identification and into the clinic.
ALL are welcome to attend our 2023 MBCGA Virtual Conference free of charge. However, your donation (no amount is too small!) will help us to continue increasing awareness and providing the most up-to-date information on breast cancer in men, advances in research and treatments, and opportunities for clinical trials, on a global scale. Thank you for your support!
Thank you to our 2023 MBCGA Virtual Conference sponsors.
REGISTRATION FOR MBCGA 2023 VIRTUAL CONFERENCE